[HTML][HTML] Leptin replacement therapy in the management of lipodystrophy syndromes
C Vigouroux, H Mosbah, C Vatier - Annales d'Endocrinologie, 2024 - Elsevier
Lipodystrophy syndromes are rare diseases of genetic or acquired origin, characterized by
quantitative and qualitative defects in adipose tissue. The metabolic consequences of …
quantitative and qualitative defects in adipose tissue. The metabolic consequences of …
[HTML][HTML] Weight-loss maintenance is accompanied by interconnected alterations in circulating FGF21-adiponectin-leptin and bioactive sphingolipids
Weight loss is often followed by weight regain. Characterizing endocrine alterations
accompanying weight reduction and regain may disentangle the complex biology of weight …
accompanying weight reduction and regain may disentangle the complex biology of weight …
Mitochondria-targeted hydrogen sulfide donor reduces fatty liver and obesity in mice fed a high fat diet by inhibiting de novo lipogenesis and inflammation via mTOR …
A Stachowicz, K Czepiel, A Wisniewska, K Stachyra… - bioRxiv, 2024 - biorxiv.org
Background: Metabolic diseases that include obesity and metabolic-associated fatty liver
disease (MAFLD) are a rapidly growing worldwide public health problem with unmet clinical …
disease (MAFLD) are a rapidly growing worldwide public health problem with unmet clinical …
[PDF][PDF] RNF125, a novel PPARγ target gene in adipogenesis
D Etteger - 2024 - studenttheses.uu.nl
Genesis of new adipocytes requires the differentiation of preadipocytes, a process known as
adipogenesis. This process necessitates a myriad of changes in protein expression and …
adipogenesis. This process necessitates a myriad of changes in protein expression and …